Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case–control study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 37, Issue 1, 2018, Pages 51-56

  Torre Cisneros, J ^a,b   Natera, C ^a,b   Mesa, F ^c   Trikic, M ^c   Rodriguez Bano J ^b,d,e  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Red Española de Investigación en Patología Infecciosa ^*  (Spain)

^c PFIZER INC   (United States)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; BACTERIAL COLONIZATION; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTICENTER STUDY (TOPIC); NONHUMAN; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; CLINICAL TRIAL; CROSS INFECTION; DRUG EFFECT; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY; RECEIVER OPERATING CHARACTERISTIC; STAPHYLOCOCCAL PNEUMONIA;

ANTIINFECTIVE AGENT;

AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA, STAPHYLOCOCCAL; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 85028958150     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-017-3100-y     Document Type: Article

References (18)

1. Torres A (2012) Antibiotic treatment against methicillin-resistant Staphylococcus aureus hospital- and ventilator-acquired pneumonia: a step forward but the battle continues. Clin Infect Dis 54:630–632
2. Bodi M, Ardanuy C, Rello J (2001) Impact of Gram-positive resistance on outcome of nosocomial pneumonia. Crit Care Medi 29(4 Suppl):N82–N86
3. Liu C, Bayer A, Cosgrove SE et al (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52:285–292
4. American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416
5. Rubinstein E, Kollef MH, Nathwani D (2008) Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46(Suppl 5):S378–S385
6. Giannella M, Pinilla B, Capdevila JA et al (2012) Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect 18:786–794
7. Wunderink RG, Niederman MS, Kollef MH et al (2012) Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 54:621–629
8. Ewig S, Welte T, Chastre J et al (2010) Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 10:279–287
9. Clinical and Laboratory Standards Institute (CLSI) (2005) Performance standards for antimicrobial susceptibility testing; Fifteenth informational supplement. CLSI/NCCLS document M100-S15. CLSI, Wayne, PA
10. Hosmer DW, Lemeshow S (2000) Logistic regression: variable selection. In: Hosmer DW, Lemeshow S (eds) Applied logistic regression, 2nd edn. John Wiley & Sons, New York, NY
11. Aliberti S, Di Pasquale M, Zanaboni AM et al (2012) Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 54:470–478
12. Aliberti S, Cilloniz C, Chalmers JD et al (2013) Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax 68:997–999
13. Shindo Y, Ito R, Kobayashi D et al (2013) Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med 188:985–995
14. Gross AE, Van Schooneveld TC, Olsen KM et al (2014) Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother 58:5262–5268
15. Graffunder EM, Venezia RA (2002) Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49:999–1005
16. Hardy KJ, Hawkey PM, Gao F et al (2004) Methicillin resistant Staphylococcus aureus in the critically ill. Br J Anaesth 92:121–130
17. Shorr AF, Zilberberg MD, Reichley R et al (2012) Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 54:193–198
18. Kalil AC, Metersky ML, Klompas M et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63:e61–e111